Side-by-side comparison of AI visibility scores, market position, and capabilities
Bellevue WA premium commercial trucks (NASDAQ: PCAR) at $33.66B 2024 revenue, $4.16B earnings, 86th consecutive profitable year; Kenworth/Peterbilt 30.7% Class 8 market share, hydrogen FCEV deliveries 2025 competing with Daimler Freightliner.
PACCAR Inc. is a Bellevue, Washington-based premium commercial truck manufacturer — publicly traded on NASDAQ (NASDAQ: PCAR) as an S&P 500 Industrials component — designing and manufacturing heavy and medium-duty trucks under the Kenworth (North America), Peterbilt (North America), and DAF (Europe) brands through manufacturing facilities in the US, Netherlands, UK, Mexico, Brazil, and Australia, reporting $33.66 billion in 2024 revenue (second-best in company history), $4.16 billion in earnings, and its 86th consecutive year of net income. Founded in 1905 by William Pigott as a steel foundry and evolving through Seattle Car Manufacturing, Pacific Car and Foundry, and ultimately PACCAR, the company has built one of the most respected brands in long-haul trucking. In 2024, Kenworth and Peterbilt combined for 30.7% US and Canadian Class 8 heavy truck retail sales market share, with 185,300 vehicles delivered globally. PACCAR Parts (aftermarket parts distribution) set records with $6.67 billion in revenue and $1.71 billion in pretax income, demonstrating the high-margin recurring revenue stream from servicing the installed base of 1+ million PACCAR trucks. For 2025, PACCAR planned $700-800 million in capital projects and $460-500 million in R&D investment, targeting electric vehicle commercial production, hydrogen fuel cell truck delivery, and autonomous driving technology development. The Amplify Cell Technologies joint venture (with Daimler Truck and Accelera by Cummins, $2-3 billion investment) localizes battery cell manufacturing for electric Class 8 trucks in the US.
Richmond VA tobacco and nicotine (NYSE: MO) ~$9.7B net revenue FY2024; Marlboro 40%+ US cigarette share, on! oral pouch competing with Zyn, 50%+ operating margins, ABI stake, competing with Reynolds/BAT.
Altria Group, Inc. is a Richmond, Virginia-based tobacco and nicotine company — publicly traded on the New York Stock Exchange (NYSE: MO) as an S&P 500 Consumer Staples component — manufacturing and selling cigarettes (Marlboro — the best-selling cigarette brand in the United States), smokeless tobacco (Copenhagen, Skoal, Red Seal, Husky chewing tobacco/moist snuff brands), oral nicotine pouches (on! brand), and maintaining a 10.7% ownership stake in Anheuser-Busch InBev (SABMiller acquisition consideration shares) and a 35% stake in JUUL Labs (vaping — original $12.8B investment written down to minimal value following JUUL's regulatory and litigation difficulties) through approximately 5,500 employees. In fiscal year 2024, Altria reported revenues of approximately $20.6 billion (net revenues after excise taxes approximately $9.7 billion), with the cigarette segment (Marlboro generating 40%+ US cigarette market share) contributing the majority of operating income at 50%+ adjusted operating margins — the highest margins in the consumer staples sector reflecting cigarettes' inelastic demand and regulated market structure. CEO Billy Gifford has pivoted Altria's strategy from cigarettes toward smoke-free nicotine products: the on! oral nicotine pouch (acquired full ownership of Helix Innovations in 2023, rebranding as on! to compete with Swedish Match Zyn, the dominant US oral nicotine pouch brand) represents Altria's primary nicotine product diversification vehicle as cigarette volume declines 7-8% annually through consumer quit rates and secular health awareness trends.
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.